JP2015513549A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015513549A5 JP2015513549A5 JP2014560104A JP2014560104A JP2015513549A5 JP 2015513549 A5 JP2015513549 A5 JP 2015513549A5 JP 2014560104 A JP2014560104 A JP 2014560104A JP 2014560104 A JP2014560104 A JP 2014560104A JP 2015513549 A5 JP2015513549 A5 JP 2015513549A5
- Authority
- JP
- Japan
- Prior art keywords
- topical formulation
- solution
- alpha connexin
- polypeptide
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261605528P | 2012-03-01 | 2012-03-01 | |
| US61/605,528 | 2012-03-01 | ||
| PCT/US2013/028727 WO2013131040A1 (en) | 2012-03-01 | 2013-03-01 | Topical gels containing alpha connexin c-terminal (act) peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015513549A JP2015513549A (ja) | 2015-05-14 |
| JP2015513549A5 true JP2015513549A5 (enExample) | 2016-04-07 |
| JP6185937B2 JP6185937B2 (ja) | 2017-08-23 |
Family
ID=49083360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014560104A Active JP6185937B2 (ja) | 2012-03-01 | 2013-03-01 | アルファコネキシンｃ末端（ａｃｔ）ペプチド含有局所用ゲル剤 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US8846605B2 (enExample) |
| EP (1) | EP2819682B1 (enExample) |
| JP (1) | JP6185937B2 (enExample) |
| KR (1) | KR102038948B1 (enExample) |
| CN (1) | CN104271142B (enExample) |
| AU (1) | AU2013225716B2 (enExample) |
| BR (1) | BR112014021653B1 (enExample) |
| CA (1) | CA2866115C (enExample) |
| DK (1) | DK2819682T3 (enExample) |
| IL (1) | IL234380B (enExample) |
| IN (1) | IN2014DN07420A (enExample) |
| MX (1) | MX351881B (enExample) |
| NZ (1) | NZ629769A (enExample) |
| RU (1) | RU2657535C2 (enExample) |
| SG (1) | SG11201405359YA (enExample) |
| WO (1) | WO2013131040A1 (enExample) |
| ZA (1) | ZA201406373B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2463181B (en) | 2007-05-14 | 2013-03-27 | Univ New York State Res Found | Induction of a physiological dispersion response in bacterial cells in a biofilm |
| RU2657535C2 (ru) | 2012-03-01 | 2018-06-14 | Ферстстринг Рисерч, Инк. | Гели для местного применения, содержащие с-концевые пептиды альфа-коннексина (act) |
| US11246821B2 (en) * | 2016-08-30 | 2022-02-15 | Rohm And Haas Company | Personal care composition |
| MX2019009753A (es) * | 2017-02-16 | 2019-12-18 | Firststring Res Inc | Composicion y metodos para prevenir lesion por radiacion y promover la regeneracion de tejidos. |
| EP3574892A4 (en) * | 2017-06-14 | 2020-08-12 | Bio Solution Co., Ltd. | COSMETIC COMPOSITION TO REDUCE WRINKLES OR INFLAMMATION, CONTAINING SUBSTANCE P |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| KR20210057072A (ko) * | 2018-09-12 | 2021-05-20 | 퍼스트스트링 리서치 인코포레이티드 | 알파 코넥신 c-말단 펩타이드에 대한 나노 입자 제제 및 사용 방법 |
| RU2691647C1 (ru) * | 2018-11-29 | 2019-06-17 | Артем Иванович Трофименко | Средство для профилактики образования патологических кожных рубцов |
| US11751056B2 (en) * | 2020-08-31 | 2023-09-05 | Oracle International Corporation | Methods, systems, and computer readable media for 5G user equipment (UE) historical mobility tracking and security screening using mobility patterns |
| CA3196342A1 (en) | 2020-10-22 | 2022-04-28 | Gautam Ghatnekar | Peptide formulations and ophthalmic uses thereof |
| WO2023212446A1 (en) * | 2022-04-29 | 2023-11-02 | Xequel Bio, Inc. | Compositions and methods for treating complications of viral infections and other respiratory disorders |
| CN117582401B (zh) * | 2023-12-07 | 2024-04-26 | 唐宁医药科技(济南)有限公司 | 一种糖尿病足凝胶及其制备方法 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3603444A1 (de) | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha |
| NZ222413A (en) | 1986-11-05 | 1991-06-25 | Ethicon Inc | Compositions containing a polypeptide growth factor and a water-soluble cellulose polymer stabiliser |
| US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| CA2080538A1 (en) * | 1991-10-21 | 1993-04-22 | Joseph V. Bondi | Lyophilized acidic fibroblast growth factor |
| US5401504B1 (en) * | 1993-12-28 | 1998-04-21 | Univ Mississippi Medical Cente | Use of tumeric in wound healing |
| FR2739621B1 (fr) | 1995-10-05 | 1997-12-05 | Centre Nat Rech Scient | Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives |
| PT1146908E (pt) | 1999-01-27 | 2005-10-31 | David Dr Becker | Formulacoes que contem nucleotidos de anti-sentido para conexinas |
| EP1178817A2 (en) | 1999-05-14 | 2002-02-13 | Arbor Vita Corporation | Molecular interactions in haematopoietic cells |
| US7250397B2 (en) | 2000-02-23 | 2007-07-31 | Zealand Pharma A/S | Antiarrhythmic peptides |
| WO2002042422A2 (en) | 2000-11-10 | 2002-05-30 | Arbor Vita Corporation | Molecular interactions in hematopoietic cells |
| WO2002088370A2 (en) | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Autogene nucleic acids encoding a secretable rna polymerase |
| US6867283B2 (en) | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
| US20050053918A1 (en) | 2001-05-16 | 2005-03-10 | Technion Research & Development Foundation Ltd. | Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses |
| CN1827766B (zh) | 2001-06-28 | 2010-08-25 | 徐荣祥 | 体外细胞的培养方法 |
| US6685971B2 (en) | 2001-06-28 | 2004-02-03 | Rongxiang Xu | Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| AU2002321903A1 (en) | 2001-08-03 | 2003-02-24 | Arbor Vita Corporation | Molecular interactions in cells |
| CA2461542A1 (en) | 2001-10-17 | 2003-04-24 | Tudor Morley Griffith | Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| JP2003238441A (ja) | 2002-02-08 | 2003-08-27 | 英行 ▲高▼野 | 血管新生抑制剤 |
| WO2003096981A2 (en) | 2002-05-15 | 2003-11-27 | Seul, Kyung, Hwan | Method of modulating angiogenesis |
| IL152573A (en) * | 2002-10-31 | 2009-11-18 | Transpharma Medical Ltd | A system for the transmission through the skin of a medical preparation against vomiting and nausea |
| US7560430B2 (en) | 2003-02-14 | 2009-07-14 | Human Matrix Sciences, Llc | Elastin digest compositions and methods utilizing same |
| AU2004294824A1 (en) | 2003-12-03 | 2005-06-16 | Coda Therapeutics (Nz) Ltd | Antisense compounds targeted to connexins and methods of use thereof |
| ZA200706016B (en) * | 2004-12-21 | 2008-12-31 | Musc Found For Res Dev | Compositions and methods for promoting wound healing and tissue regeneration |
| US9408381B2 (en) | 2004-12-21 | 2016-08-09 | Musc Foundation For Research Development | Alpha Connexin c-Terminal (ACT) peptides for use in transplant |
| EP2289535B8 (en) | 2004-12-21 | 2018-08-08 | MUSC Foundation for Research Development | Compositions and methods for promoting wound healing and tissue regeneration |
| CA2596412A1 (en) | 2005-02-03 | 2006-12-21 | Coda Therapeutics Limited | Anti-connexin compounds and uses thereof |
| CA2612522A1 (en) * | 2005-06-17 | 2006-12-28 | Regenerx Biopharmaceuticals, Inc. | Lkktet and/or lkktnt peptide compositions and methods |
| CN101198346A (zh) * | 2005-06-17 | 2008-06-11 | 雷金纳克斯生物制药公司 | Lkktet和/或lkktnt肽组合物及方法 |
| US8128947B2 (en) * | 2005-10-11 | 2012-03-06 | Dpt Laboratories, Ltd. | Surfactant-free dispersions, compositions, and use in topical formulations |
| GB0709513D0 (en) * | 2007-05-17 | 2007-06-27 | Helperby Therapeutics Ltd | Topical formulations |
| KR20150072458A (ko) | 2006-11-15 | 2015-06-29 | 코다 테라퓨틱스, 인크. | 상처 치유를 위한 개선 방법 및 조성물 |
| RU2521329C2 (ru) | 2006-12-11 | 2014-06-27 | Коуда Терапьютикс, Инк. | Композиции и способы лечения плохо заживающих ран |
| WO2008150929A1 (en) * | 2007-05-29 | 2008-12-11 | Manhattan Pharmaceuticals, Inc. | Topical compositions comprising a macromolecule and methods of using same |
| US20110130345A1 (en) | 2007-06-21 | 2011-06-02 | Baerbel Rohrer | Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration |
| CA2592285C (en) | 2007-06-28 | 2019-10-01 | Musc Foundation For Research Development | Compositions comprising connexin polypeptides and methods for promoting wound healing and tissue regeneration using connexin polypeptides |
| CN101970663A (zh) | 2007-12-11 | 2011-02-09 | 科达治疗公司 | 受损伤口愈合的组合物和治疗 |
| JP2011506446A (ja) * | 2007-12-11 | 2011-03-03 | コーダ セラピューティクス， インコーポレイテッド | 損傷した創傷治癒組成物および治療 |
| CA2710382A1 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Treatment of orthopedic conditions |
| EP2252690A2 (en) | 2007-12-21 | 2010-11-24 | Coda Therapeutics, Inc. | Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| US20130184220A1 (en) | 2007-12-21 | 2013-07-18 | Bradford James Duft | Treatment of abnormal or excessive scars |
| CA2710375A1 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Treatment of orthopedic conditions |
| EP2234656A2 (en) | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Improved medical devices |
| CA2710387A1 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Treatment of fibrotic conditions |
| EP2237796A2 (en) | 2007-12-21 | 2010-10-13 | Coda Therapeutics, Inc. | Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions |
| WO2009085270A2 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions |
| EP2252689A2 (en) | 2007-12-21 | 2010-11-24 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides for the treatment of surgical adhesions |
| EP2240583A2 (en) * | 2008-01-07 | 2010-10-20 | Coda Therapeutics, Inc. | Wound healing compositions and treatments |
| JP2011524345A (ja) | 2008-06-04 | 2011-09-01 | コーダ セラピューティクス， インコーポレイテッド | ギャップジャンクション調節化合物を用いる疼痛の治療 |
| EP2586436A1 (en) | 2011-10-31 | 2013-05-01 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitor |
| RU2657535C2 (ru) | 2012-03-01 | 2018-06-14 | Ферстстринг Рисерч, Инк. | Гели для местного применения, содержащие с-концевые пептиды альфа-коннексина (act) |
-
2013
- 2013-03-01 RU RU2014139668A patent/RU2657535C2/ru active
- 2013-03-01 AU AU2013225716A patent/AU2013225716B2/en not_active Ceased
- 2013-03-01 NZ NZ629769A patent/NZ629769A/en not_active IP Right Cessation
- 2013-03-01 CN CN201380023492.XA patent/CN104271142B/zh active Active
- 2013-03-01 MX MX2014010501A patent/MX351881B/es active IP Right Grant
- 2013-03-01 JP JP2014560104A patent/JP6185937B2/ja active Active
- 2013-03-01 SG SG11201405359YA patent/SG11201405359YA/en unknown
- 2013-03-01 DK DK13755720.3T patent/DK2819682T3/en active
- 2013-03-01 BR BR112014021653-3A patent/BR112014021653B1/pt active IP Right Grant
- 2013-03-01 CA CA2866115A patent/CA2866115C/en active Active
- 2013-03-01 WO PCT/US2013/028727 patent/WO2013131040A1/en not_active Ceased
- 2013-03-01 KR KR1020147027397A patent/KR102038948B1/ko active Active
- 2013-03-01 EP EP13755720.3A patent/EP2819682B1/en active Active
- 2013-03-15 US US13/815,723 patent/US8846605B2/en active Active
-
2014
- 2014-07-25 US US14/341,406 patent/US9161984B2/en active Active
- 2014-08-29 ZA ZA2014/06373A patent/ZA201406373B/en unknown
- 2014-08-31 IL IL234380A patent/IL234380B/en active IP Right Grant
- 2014-09-03 IN IN7420DEN2014 patent/IN2014DN07420A/en unknown
-
2015
- 2015-09-09 US US14/848,916 patent/US10632173B2/en active Active
-
2020
- 2020-04-27 US US16/859,075 patent/US11524049B2/en active Active
-
2022
- 2022-10-06 US US17/938,624 patent/US12128086B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015513549A5 (enExample) | ||
| RU2014139668A (ru) | Гели для местного применения, содержащие с-концевые пептиды альфа-коннексина (act) | |
| BR112016002939A2 (pt) | composições farmacêuticas parenterais aquosas estáveis de peptídeos insulinotrópicos | |
| ES2236010T3 (es) | Composiciones de polipeptidos con estabilidad mejorada. | |
| JP2014515747A5 (enExample) | ||
| CN103830720A (zh) | 一种含缩宫素的药物组合物 | |
| BRPI0616300A2 (pt) | formulaÇço aquosa de hfsh | |
| JP2009528372A5 (enExample) | ||
| ES2961458T3 (es) | Composición líquida estable que comprende toxina botulínica | |
| HRP20221355T1 (hr) | Liofilizirani pripravak citotoksičnih dipeptida | |
| JP2015508771A5 (enExample) | ||
| AR079896A1 (es) | Proceso para preparar composiciones farmaceuticas para la liberacion sostenida de analogos de somatostatina | |
| Dong et al. | Efficient delivery of VEGFA mRNA for promoting wound healing via ionizable lipid nanoparticles | |
| JP2019070016A (ja) | ヘプラペプチドの製剤 | |
| CN106137817A (zh) | 牙膏 | |
| CN105432598A (zh) | 一种液基细胞保存液及其制备方法 | |
| JP2013523778A5 (enExample) | ||
| CN104558150A (zh) | 一类新型生长激素释放激素类似肽及其在制备治疗不孕不育药物中的应用 | |
| RU2016119565A (ru) | Полипептиды длительного действия и способы их получения и введения | |
| Cheng et al. | Mesenchymal Stem Cell Therapy: Therapeutic Opportunities and Challenges for Diabetic Kidney Disease | |
| JP6125141B2 (ja) | 点眼剤 | |
| JP2016535015A5 (enExample) | ||
| CN103143000B (zh) | 一种重组人干扰素α2b制剂 | |
| Guo et al. | Peptide amphiphiles alleviate myocardial Endoplasmic reticulum stress to enhance cardiomyocyte–macrophage communication and promote macrophage M2 polarization | |
| CN104069129A (zh) | 一种治疗牛皮癣和皮炎的外涂液及其制备方法与应用 |